These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 24214491)

  • 1. Sex dependent pharmacokinetics and bioequivalence--time for a change.
    Koren G
    J Popul Ther Clin Pharmacol; 2013; 20(3):e358-61. PubMed ID: 24214491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioequivalence studies of drugs prescribed mainly for women.
    McGilveray IJ
    J Popul Ther Clin Pharmacol; 2011; 18(3):e516-22. PubMed ID: 22113364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics in pregnancy; clinical significance.
    Koren G
    J Popul Ther Clin Pharmacol; 2011; 18(3):e523-7. PubMed ID: 22113390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drugs indicated for use during pregnancy.
    Lalonde AB
    J Popul Ther Clin Pharmacol; 2011; 18(3):e513-5. PubMed ID: 22113337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and inference for 3-stage bioequivalence testing with serial sampling data.
    Yan F; Zhu H; Liu J; Jiang L; Huang X
    Pharm Stat; 2018 Sep; 17(5):458-476. PubMed ID: 29726096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of metabolites in bioequivalence.
    Midha KK; Rawson MJ; Hubbard JW
    Pharm Res; 2004 Aug; 21(8):1331-44. PubMed ID: 15359567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Bayesian methods for multivariate bioequivalence measures.
    Molina de Souza R; Achcar JA; Martinez EZ
    J Biopharm Stat; 2009; 19(1):42-66. PubMed ID: 19127466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic analysis of bioequivalence trials: implications for sex-related issues in clinical pharmacology and biopharmaceutics.
    Chen ML; Lee SC; Ng MJ; Schuirmann DJ; Lesko LJ; Williams RL
    Clin Pharmacol Ther; 2000 Nov; 68(5):510-21. PubMed ID: 11103754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioequivalence studies: a new EMA guideline.
    Houin G
    Arzneimittelforschung; 2010; 60(4):169-70. PubMed ID: 20486464
    [No Abstract]   [Full Text] [Related]  

  • 10. Sex Effect on Average Bioequivalence.
    Ibarra M; Vázquez M; Fagiolino P
    Clin Ther; 2017 Jan; 39(1):23-33. PubMed ID: 28034518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sample size determination in bioequivalence studies using statistical assurance.
    Ring A; Lang B; Kazaroho C; Labes D; Schall R; Schütz H
    Br J Clin Pharmacol; 2019 Oct; 85(10):2369-2377. PubMed ID: 31276603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the reference scaled bioequivalence semi-replicate method with other approaches: focus on human exposure to drugs.
    Karalis V; Symillides M; Macheras P
    Eur J Pharm Sci; 2009 Aug; 38(1):55-63. PubMed ID: 19524039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex differences in pharmacokinetics and pharmacodynamics.
    Soldin OP; Mattison DR
    Clin Pharmacokinet; 2009; 48(3):143-57. PubMed ID: 19385708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carryover negligibility and relevance in bioequivalence studies.
    Ocaña J; Sanchez O MP; Carrasco JL
    Pharm Stat; 2015; 14(5):400-8. PubMed ID: 26175204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biowaiver: an alternative to in vivo pharmacokinetic bioequivalence studies.
    Mishra V; Gupta U; Jain NK
    Pharmazie; 2010 Mar; 65(3):155-61. PubMed ID: 20383933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolites and bioequivalence: past and present.
    Jackson AJ; Robbie G; Marroum P
    Clin Pharmacokinet; 2004; 43(10):655-72. PubMed ID: 15244496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 10th Anniversary of a Two-Stage Design in Bioequivalence. Why Has it Still Not Been Implemented?
    Kaza M; Sokolovskyi A; Rudzki PJ
    Pharm Res; 2020 Jul; 37(7):140. PubMed ID: 32661944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computer simulations for bioequivalence trials: Selection of analyte in BCS class II and IV drugs with first-pass metabolism, two metabolic pathways and intestinal efflux transporter.
    Mangas-Sanjuan V; Navarro-Fontestad C; García-Arieta A; Trocóniz IF; Bermejo M
    Eur J Pharm Sci; 2018 May; 117():193-203. PubMed ID: 29452210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioequivalence studies: single vs multiple dose.
    Steinijans VW; Sauter R; Jonkman JH; Schulz HU; Stricker H; Blume H
    Int J Clin Pharmacol Ther Toxicol; 1992; 30 Suppl 1():S31-6. PubMed ID: 1601529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of Orally Inhaled Drug Products.
    Hochhaus G; Horhota S; Hendeles L; Suarez S; Rebello J
    AAPS J; 2015 May; 17(3):769-75. PubMed ID: 25762449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.